Content area
Full Text
OBJECTIVE-The G6PC2 gene encoding islet-specific glucose-6-phosphatase related protein (IGRP) has a common promoter variant, rs573225 (-231G/A), located within a Foxa binding site. We tested the cis-regulatory effects of rs573225 on promoter activity and its association with insulin response to oral glucose.
RESEARCH DESIGN AND METHODS-Functional effects of rs573225 were explored in transfected INS-1 and HIT-T β-cell lines. A total of 734 young obese subjects of European ancestry were genotyped for rs573225. Insulin and glucose levels were measured in response to oral glucose, and the insulinogenic index (IGI) of insulin secretion was calculated.
RESULTS-In vitro, the G allele showed a higher affinity for binding Foxa2 transcription factor and increased G6PC2 promoter activity. Foxa2 binding is modified if the C adjacent to the G allele is methylated. IGI was associated with rs573225 by linear regression analysis and was 30% greater in AA or AG than in GG obese children. rs573225 was also associated with fasting glucose.
CONCLUSIONS-rs573225 is a functional cis-regulatory (epi)-single-nucleotide polymorphism (SNP) of G6PC2 associated with glucose-insulin homeostasis in obese children, likely to explain the results of recent genome-wide association studies in nondiabetic adults. Diabetes 58:489-492, 2009
The flux through glycolysis is the sensed process that makes ß-cells glucose responsive. Thus, altered kinetics of glucose-induced insulin secretion could result from a changed intrinsic activity, cellular level, or allosteric regulation of several enzymes including glucokinase, phospho-fructokinase, G6PC2 (glucose-6-phosphatase, catalytic, 2), or others involved in the regulation of cellular glucose-6-phosphate (G6P) content. Whereas glucokinase, a high K^sub m^ enzyme, phosphorylates glucose into G6P in β-cells, G6PC2, a low Km enzyme, catalyzes G6P dephosphorylation (1), which could antagonize insulin secretion (2). In mice, G6PC2 has only -5% of the activity of liver G6Pase (1), sufficient however for the knockout of G6PC2 to result in a small decrease in glycemia (3). The human G6PC2 gene is located in 2q24 in a region that we found linked to glycemia (4). The G6PC2 promoter is inactive in HepG2 cells but has 150-fold more activity in HIT-T 15 β-cells, due to the region located between -306 and +3 (5). This proximal promoter region regulates G6PC2 expression in transiently transfected βTC-3, HIT-T15, and Min6 cells through the bmding of Foxa2 and MafA transcription factors (6). We found three single-nucleotide polymorphisms (SNPs) in...